SI1951759T1 - Protitelesa anti-EGFR - Google Patents
Protitelesa anti-EGFRInfo
- Publication number
- SI1951759T1 SI1951759T1 SI200630693T SI200630693T SI1951759T1 SI 1951759 T1 SI1951759 T1 SI 1951759T1 SI 200630693 T SI200630693 T SI 200630693T SI 200630693 T SI200630693 T SI 200630693T SI 1951759 T1 SI1951759 T1 SI 1951759T1
- Authority
- SI
- Slovenia
- Prior art keywords
- egfr antibodies
- egfr
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73536305P | 2005-11-12 | 2005-11-12 | |
PCT/US2006/043311 WO2007058823A2 (en) | 2005-11-12 | 2006-11-06 | Anti-egfr antibodies |
EP06837044A EP1951759B1 (en) | 2005-11-12 | 2006-11-06 | Anti-egfr antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1951759T1 true SI1951759T1 (sl) | 2010-08-31 |
Family
ID=42664730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200630693T SI1951759T1 (sl) | 2005-11-12 | 2006-11-06 | Protitelesa anti-EGFR |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1951759B1 (sl) |
PL (1) | PL1951759T3 (sl) |
SI (1) | SI1951759T1 (sl) |
-
2006
- 2006-11-06 PL PL06837044T patent/PL1951759T3/pl unknown
- 2006-11-06 SI SI200630693T patent/SI1951759T1/sl unknown
- 2006-11-06 EP EP06837044A patent/EP1951759B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
EP1951759B1 (en) | 2010-03-17 |
EP1951759A2 (en) | 2008-08-06 |
PL1951759T3 (pl) | 2010-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1218126A1 (zh) | 抗體 | |
HRP20150176T1 (en) | Anti-myostatin antibodies | |
IL181575A0 (en) | Anti-ox40l antibodies | |
IL228033A0 (en) | Antibodies | |
IL189579A0 (en) | Anti-myostatin antibodies | |
IL187106A (en) | Sclerostin binds antibody | |
IL190472A0 (en) | Anti-glypican-3 antibody | |
IL185366A0 (en) | Antibody | |
GB0517487D0 (en) | Antibodies | |
GB0420466D0 (en) | Anti-glucan antibodies | |
ZA200701952B (en) | Anti-OX40L antibodies | |
EP1896047A4 (en) | ANTI-GFRALPHA3 ANTIBODIES | |
GB0505489D0 (en) | Antibodies | |
GB0512278D0 (en) | Antibodies | |
GB0505054D0 (en) | Antibodies | |
PL1951759T3 (pl) | Przeciwciała anty-EGFR | |
GB0519883D0 (en) | Antibodies | |
GB0402641D0 (en) | Antibodies | |
GB0402642D0 (en) | Antibodies | |
GB0506945D0 (en) | Human antibodies | |
GB0503190D0 (en) | Human antibodies | |
GB0502201D0 (en) | Human antibodies | |
GB0413479D0 (en) | Novel antibodies | |
GB0500400D0 (en) | Antibody |